WESPAC Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
WESPAC Advisors's LLY Position: Q1 2026 in Review
WESPAC Advisors reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $40.6K and leaving 492 shares worth $453K. The position accounts for 0.25% of the portfolio, ranked #113.
WESPAC Advisors first reported a position in LLY in Q1 2019 and has held it in 17 quarters since. The position peaked at $2.59M in Q1 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- WESPAC Advisors held 492 shares of Eli Lilly worth $453K as of Q1 2026.
- WESPAC Advisors sold 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.25% of WESPAC Advisors's portfolio in Q1 2026, its #113 holding.
- WESPAC Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 17 quarters since.
- WESPAC Advisors's Eli Lilly position peaked at $2.59M in Q1 2019.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on WESPAC Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.